Overview
Diana Douglas focuses her practice on corporate, securities and transactional matters. Diana advises clients on public company reporting and disclosure compliance, public and private offerings of equity and debt securities, mergers and acquisitions, corporate restructurings and commercial transactions. She also counsels clients on general corporate and corporate governance matters.
Diana regularly serves as primary outside counsel for clients.
Diana represents clients from a broad array of industries, including companies in the technology and life sciences sectors.
Results
- Represented Constellation Brands, Inc. (NYSE: STZ) in its $1 billion public offering of 2.250% senior notes due 2031
- Represented Healthcare Trust of America, Inc. (NYSE: HTA) in its at-the-market program for the sale of up to $750 million of Class A common stock
- Represented the underwriters of AvalonBay Communities, Inc. (NYSE: AVB), in its public green bond offering of $700 million of 2.050% senior notes due 2032
- Represented SAP SE (NYSE: SAP) in its strategic acquisition of no code/low code software company, AppGyver
- Represented QuantumWise, a Denmark-based software company, in connection with its sale to Synopsys (NASDAQ: SNPS)
- Represented Virttu Biologics Ltd., a UK-based life sciences company, in its sale to Sorrento Therapeutics, Inc.
- Represented Apollo Medical Holdings, Inc. (NASDAQ: AMEH), a physician practice management company, in its business combination transaction with Network Medical Management, Inc.
Credentials
Education
Santa Clara University School of Law, JD, 2015
University of California – Los Angeles, BA, 2009
Admissions
California
